Related Experiment Videos
Coronary artery surgery and direct coronary artery thrombolysis during acute myocardial infarction
Insights
Direct coronary artery streptokinase thrombolysis successfully restored blood flow and salvaged myocardium in most acute myocardial infarction patients. Early coronary bypass surgery is recommended to prevent reinfarction and ensure long-term success.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Medicine
Background:
- Acute myocardial infarction (MI) remains a leading cause of mortality worldwide.
- Reperfusion therapy is critical for limiting infarct size and improving outcomes.
- Thrombolysis, particularly direct coronary artery administration, is a key reperfusion strategy.
Purpose of the Study:
- To evaluate the efficacy and safety of direct coronary artery streptokinase thrombolysis in acute evolving myocardial infarction.
- To assess the rates of myocardial salvage, clinical stabilization, and subsequent coronary artery bypass surgery outcomes.
- To determine the optimal timing for coronary artery bypass surgery following successful thrombolysis.
Main Methods:
- Twelve patients with acute myocardial infarction received direct coronary artery streptokinase thrombolysis.
- Outcomes assessed included restoration of coronary blood flow, myocardial salvage, and clinical status.
- Subsequent coronary artery bypass surgery was performed in nine patients, with varying delays.
Main Results:
- Ten patients achieved restoration of coronary blood flow.
- Eight patients demonstrated significant myocardial salvage and clinical stabilization.
- Nine patients underwent successful coronary artery bypass surgery without major complications, with five having immediate surgery.
Conclusions:
- Direct coronary artery streptokinase thrombolysis is effective in restoring blood flow and salvaging myocardium during acute myocardial infarction.
- Early coronary artery bypass surgery following thrombolysis is crucial for preventing reinfarction and ensuring sustained benefits.
- Delaying bypass surgery in patients who have improved with thrombolysis may increase the risk of reinfarction.
Abstract:
Twelve patients underwent direct coronary artery streptokinase thrombolysis during acute evolving myocardial infarction. Ten patients had restoration of orthograde pulmonary blood flow. Eight patients had significant myocardial salvage and clinical stabilization. Nine patients had subsequent coronary artery bypass surgery with no major hematological or cardiac complications. Five of these had surgery performed immediately. Two patients with no myocardial salvage after streptokinase had urgent surgery because of other critical coronary lesions. Seven patients with thrombolytic salvage of myocardium underwent urgent coronary artery bypass surgery without incident. The occurrence of two reinfarctions in streptokinase-improved patients waiting for surgery suggests that delay is unwarranted and coronary bypass surgery is needed to insure success.